{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:47:07Z","timestamp":1790808427630,"version":"4.1.0"},"reference-count":43,"publisher":"China Science Publishing & Media Ltd.","issue":"10","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2025,10,1]]},"DOI":"10.3724\/abbs.2025034","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T22:11:10Z","timestamp":1740694270000},"page":"1589-1600","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":5,"title":["Melatonin attenuates kidney injury by alleviating lysosomal damage in diabetic kidney disease"],"prefix":"10.3724","volume":"57","author":[{"given":"Jiaqi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoquan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aomiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geningyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoming","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijie","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongji","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2025,6,13]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"15018","DOI":"10.1038\/nrdp.2015.18","volume":"1","author":"Thomas MC","year":"2015","unstructured":"Thomas MC, Brownlee M, Susztak K, Sharma K, Jandeleit-Dahm KAM, Zoungas S, Rossing P. Diabetic kidney disease. Nat Rev Dis Primers, 2015, 1:","journal-title":"Nat Rev Dis Primers"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.kint.2022.05.012","volume":"102","author":"Tuttle KR","year":"2022","unstructured":"Tuttle KR, Agarwal R, Alpers CE, Bakris GL, Brosius FC, Kolkhof P, Uribarri J. Molecular mechanisms and therapeutic targets for diabetic kidney disease. Kidney Int, 2022, 102: 248-260.","journal-title":"Kidney Int"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S2213-8587(18)30313-9","volume":"7","author":"Coresh J","year":"2019","unstructured":"Coresh J, Heerspink HJL, Sang Y, Matsushita K, Arnlov J, Astor BC, Black C. Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies. Lancet Diabetes Endocrinol, 2019, 7: 115-127.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/S2213-8587(18)30314-0","volume":"7","author":"Heerspink HJL","year":"2019","unstructured":"Heerspink HJL, Greene T, Tighiouart H, Gansevoort RT, Coresh J, Simon AL, Chan TM. Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials. Lancet Diabetes Endocrinol, 2019, 7: 128-139.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1681\/ASN.2006040377","volume":"17","author":"Abbate M","year":"2006","unstructured":"Abbate M, Zoja C, Remuzzi G. How does proteinuria cause progressive renal damage?. J Am Soc Nephrol, 2006, 17: 2974-2984.","journal-title":"J Am Soc Nephrol"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.ymthe.2019.05.019","volume":"27","author":"Jia Y","year":"2019","unstructured":"Jia Y, Zheng Z, Xue M, Zhang S, Hu F, Li Y, Yang Y. Extracellular vesicles from albumin-induced tubular epithelial cells promote the m1 macrophage phenotype by targeting klotho. Mol Ther, 2019, 27: 1452-1466.","journal-title":"Mol Ther"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"1139444","DOI":"10.3389\/fendo.2023.1139444","volume":"14","author":"Han YP","year":"2023","unstructured":"Han YP, Liu LJ, Yan JL, Chen MY, Meng XF, Zhou XR, Qian LB. Autophagy and its therapeutic potential in diabetic nephropathy. Front Endocrinol, 2023, 14:","journal-title":"Front Endocrinol"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00018-017-2639-1","volume":"75","author":"Yang D","year":"2018","unstructured":"Yang D, Livingston MJ, Liu Z, Dong G, Zhang M, Chen JK, Dong Z. Autophagy in diabetic kidney disease: regulation, pathological role and therapeutic potential. Cell Mol Life Sci, 2018, 75: 669-688.","journal-title":"Cell Mol Life Sci"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cell.2018.09.048","volume":"176","author":"Levine B","year":"2019","unstructured":"Levine B, Kroemer G. Biological functions of autophagy genes: a disease perspective. Cell, 2019, 176: 11-42.","journal-title":"Cell"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41421-020-0141-7","volume":"6","author":"Yim WWY","year":"2020","unstructured":"Yim WWY, Mizushima N. Lysosome biology in autophagy. Cell Discov, 2020, 6:","journal-title":"Cell Discov"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"20499","DOI":"10.1074\/jbc.M115.666354","volume":"290","author":"Liu WJ","year":"2015","unstructured":"Liu WJ, Shen TT, Chen RH, Wu HL, Wang YJ, Deng JK, Chen QH. Autophagy-lysosome pathway in renal tubular epithelial cells is disrupted by advanced glycation end products in diabetic nephropathy. J Biol Chem, 2015, 290: 20499-20510.","journal-title":"J Biol Chem"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.lfs.2019.05.069","volume":"230","author":"Medina-Navarro R","year":"2019","unstructured":"Medina-Navarro R, Torres-Ramos YD, Guzm\u00e1n-Grenfell AM, D\u00edaz-Flores M, Le\u00f3n-Reyes G, Hicks G. JJ. Lysosomal dysfunction induced by changes in albumin\u2032s tertiary structure: potential key factor in protein toxicity during diabetic nephropathy. Life Sci, 2019, 230: 197-207.","journal-title":"Life Sci"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.biochi.2017.02.004","volume":"135","author":"Peres GB","year":"2017","unstructured":"Peres GB, Schor N, Michelacci YM. Impact of high glucose and AGEs on cultured kidney-derived cells. Effects on cell viability, lysosomal enzymes and effectors of cell signaling pathways. Biochimie, 2017, 135: 137-148.","journal-title":"Biochimie"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1080\/15548627.2020.1824694","volume":"17","author":"Yang C","year":"2021","unstructured":"Yang C, Chen XC, Li ZH, Wu HL, Jing KP, Huang XR, Ye L. SMAD3 promotes autophagy dysregulation by triggering lysosome depletion in tubular epithelial cells in diabetic nephropathy. Autophagy, 2021, 17: 2325-2344.","journal-title":"Autophagy"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/s41419-019-2002-6","volume":"10","author":"Liu WJ","year":"2019","unstructured":"Liu WJ, Gan Y, Huang WF, Wu H, Zhang X, Zheng HJ, Liu H. Lysosome restoration to activate podocyte autophagy: a new therapeutic strategy for diabetic kidney disease. Cell Death Dis, 2019, 10:","journal-title":"Cell Death Dis"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"8276","DOI":"10.1111\/jcmm.15301","volume":"24","author":"Zheng HJ","year":"2020","unstructured":"Zheng HJ, Zhang X, Guo J, Zhang W, Ai S, Zhang F, Wang Y. Lysosomal dysfunction-induced autophagic stress in diabetic kidney disease. J Cell Mol Medi, 2020, 24: 8276-8290.","journal-title":"J Cell Mol Medi"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.biocel.2005.08.020","volume":"38","author":"Hardeland R","year":"2006","unstructured":"Hardeland R, Pandi-Perumal SR, Cardinali DP. Melatonin. Int J Biochem Cell Biol, 2006, 38: 313-316.","journal-title":"Int J Biochem Cell Biol"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.3390\/biom10091211","volume":"10","author":"Chitimus DM","year":"2020","unstructured":"Chitimus DM, Popescu MR, Voiculescu SE, Panaitescu AM, Pavel B, Zagrean L, Zagrean AM. Melatonin\u2019s impact on antioxidative and anti-inflammatory reprogramming in homeostasis and disease. Biomolecules, 2020, 10:","journal-title":"Biomolecules"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"105279","DOI":"10.1016\/j.phrs.2020.105279","volume":"163","author":"Wu J","year":"2021","unstructured":"Wu J, Bai Y, Wang Y, Ma J. Melatonin and regulation of autophagy: mechanisms and therapeutic implications. Pharmacol Res, 2021, 163:","journal-title":"Pharmacol Res"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12986-019-0419-7","volume":"17","author":"Ebaid H","year":"2020","unstructured":"Ebaid H, Bashandy SAE, Abdel-Mageed AM, Al-Tamimi J, Hassan I, Alhazza IM. Folic acid and melatonin mitigate diabetic nephropathy in rats via inhibition of oxidative stress. Nutr Metab (Lond), 2020, 17:","journal-title":"Nutr Metab (Lond)"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1159\/000493380","volume":"43","author":"Liu F","year":"2018","unstructured":"Liu F, Zhang S, Xu R, Gao S, Yin J. Melatonin attenuates endothelial-to-mesenchymal transition of glomerular endothelial cells via regulating miR-497\/ROCK in diabetic nephropathy. Kidney Blood Press Res, 2018, 43: 1425-1436.","journal-title":"Kidney Blood Press Res"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s13340-016-0268-9","volume":"7","author":"Motawi TK","year":"2016","unstructured":"Motawi TK, Ahmed SA, Hamed MA, El-Maraghy SA, Aziz WM. Combination of melatonin and certain drugs for treatment of diabetic nephropathy in streptozotocin-induced diabetes in rats. Diabetol Int, 2016, 7: 413-424.","journal-title":"Diabetol Int"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"122108","DOI":"10.1016\/j.lfs.2023.122108","volume":"332","author":"Fang X","year":"2023","unstructured":"Fang X, Huang W, Sun Q, Zhao Y, Sun R, Liu F, Huang D. Melatonin attenuates cellular senescence and apoptosis in diabetic nephropathy by regulating STAT3 phosphorylation. Life Sci, 2023, 332:","journal-title":"Life Sci"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3892\/mmr.2016.5313","volume":"14","author":"Ji ZZ","year":"2016","unstructured":"Ji ZZ, Xu YC. Melatonin protects podocytes from angiotensin II-induced injury in an in vitro diabetic nephropathy model. Mol Med Rep, 2016, 14: 920-926.","journal-title":"Mol Med Rep"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"889729","DOI":"10.3389\/fendo.2022.889729","volume":"13","author":"Tang H","year":"2022","unstructured":"Tang H, Yang M, Liu Y, Zhu X, Liu S, Liu H, Sun L. Melatonin alleviates renal injury by activating mitophagy in diabetic nephropathy. Front Endocrinol, 2022, 13:","journal-title":"Front Endocrinol"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.3390\/antiox12091716","volume":"12","author":"Ma Y","year":"2023","unstructured":"Ma Y, Ma J, Lu L, Xiong X, Shao Y, Ren J, Yang J. Melatonin restores autophagic flux by activating the sirt3\/TFEB signaling pathway to attenuate doxorubicin-induced cardiomyopathy. Antioxidants, 2023, 12:","journal-title":"Antioxidants"},{"key":"CITATION27","unstructured":"Moharrami Kasmaie F, Jahromi Z, Gazor R, Zaminy A. Comparison of melatonin and curcumin effect at the light and dark periods on regeneration of sciatic nerve crush injury in rats.  Excli j  2019, 18:653\u2013665."},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/s41419-021-04271-w","volume":"12","author":"Wu M","year":"2021","unstructured":"Wu M, Zhang M, Zhang Y, Li Z, Li X, Liu Z, Liu H. Relationship between lysosomal dyshomeostasis and progression of diabetic kidney disease. Cell Death Dis, 2021, 12:","journal-title":"Cell Death Dis"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/jpi.12264","volume":"59","author":"Fern\u00e1ndez A","year":"2015","unstructured":"Fern\u00e1ndez A, Ord\u00f3\u00f1ez R, Reiter RJ, Gonz\u00e1lez\u2010Gallego J, Mauriz JL. Melatonin and endoplasmic reticulum stress: relation to autophagy and apoptosis. J Pineal Res, 2015, 59: 292-307.","journal-title":"J Pineal Res"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"181","DOI":"10.4093\/dmj.2021.0329","volume":"46","author":"Jung CY","year":"2022","unstructured":"Jung CY, Yoo TH. Pathophysiologic mechanisms and potential biomarkers in diabetic kidney disease. Diabetes Metab J, 2022, 46: 181-197.","journal-title":"Diabetes Metab J"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"193757","DOI":"10.1155\/2013\/193757","volume":"2013","author":"Yamahara K","year":"2013","unstructured":"Yamahara K, Yasuda M, Kume S, Koya D, Maegawa H, Uzu T. The role of autophagy in the pathogenesis of diabetic nephropathy. J Diabetes Res, 2013, 2013:","journal-title":"J Diabetes Res"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"113803","DOI":"10.1016\/j.ecoenv.2022.113803","volume":"241","author":"Ding F","year":"2022","unstructured":"Ding F, Zhang L, Wu X, Liu Y, Wan Y, Hu J, Zhang X. Melatonin ameliorates renal dysfunction in glyphosate- and hard water-treated mice. Ecotoxicol Environ Saf, 2022, 241:","journal-title":"Ecotoxicol Environ Saf"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"BSR20181614","DOI":"10.1042\/BSR20181614","volume":"39","author":"Shi S","year":"2019","unstructured":"Shi S, Lei S, Tang C, Wang K, Xia Z. Melatonin attenuates acute kidney ischemia\/reperfusion injury in diabetic rats by activation of the SIRT1\/Nrf2\/HO-1 signaling pathway. Biosci Rep, 2019, 39:","journal-title":"Biosci Rep"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"20190036","DOI":"10.1515\/hmbci-2019-0036","volume":"40","author":"Mok JX","year":"2019","unstructured":"Mok JX, Ooi JH, Ng KY, Koh RY, Chye SM. A new prospective on the role of melatonin in diabetes and its complications. Hormone Mol Biol Clin Invest, 2019, 40:","journal-title":"Hormone Mol Biol Clin Invest"},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/jpi.12054","volume":"55","author":"\u015eehirli A","year":"2013","unstructured":"\u015eehirli A, Koyun D, Tetik \u015e, \u00d6zsavc\u0131 D, Yi\u011finer \u00d6, \u00c7etinel \u015e, Tok OE. Melatonin protects against ischemic heart failure in rats. J Pineal Res, 2013, 55: 138-148.","journal-title":"J Pineal Res"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"5861553","DOI":"10.1155\/2022\/5861553","volume":"2022","author":"Zhang Z","year":"2022","unstructured":"Zhang Z, Zhang M, Zhang Z, Sun Y, Wang J, Chang C, Zhu X. ADSCs combined with melatonin promote peripheral nerve regeneration through autophagy. Int J Endocrinol, 2022, 2022:","journal-title":"Int J Endocrinol"},{"key":"CITATION37","doi-asserted-by":"publisher","first-page":"583528","DOI":"10.3389\/fphar.2020.583528","volume":"11","author":"Gu YY","year":"2021","unstructured":"Gu YY, Lu FH, Huang XR, Zhang L, Mao W, Yu XQ, Liu XS. Non-Coding RNAs as biomarkers and therapeutic targets for diabetic kidney disease. Front Pharmacol, 2021, 11:","journal-title":"Front Pharmacol"},{"key":"CITATION38","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1590\/2175-8239-jbn-2018-0165","volume":"41","author":"Nascimento LR","year":"2019","unstructured":"Nascimento LR, Domingueti CP. MicroRNAs: new biomarkers and promising therapeutic targets for diabetic kidney disease. J Bras Nefrol, 2019, 41: 412-422.","journal-title":"J Bras Nefrol"},{"key":"CITATION39","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1160\/TH04-01-0023","volume":"91","author":"Gonias S","year":"2004","unstructured":"Gonias S, Wu L, Salicioni A. Low density lipoprotein receptor-related protein: regulation of the plasma membrane proteome. Thromb Haemost, 2004, 91: 1056-1064.","journal-title":"Thromb Haemost"},{"key":"CITATION40","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1046\/j.1538-7836.2003.00330.x","volume":"1","author":"Strickland DK","year":"2003","unstructured":"Strickland DK, Ranganathan S. Diverse role of LDL receptor-related protein in the clearance of proteases and in signaling. J Thrombosis Haemostasis, 2003, 1: 1663-1670.","journal-title":"J Thrombosis Haemostasis"},{"key":"CITATION41","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.1172\/JCI32301","volume":"117","author":"Hu K","year":"2007","unstructured":"Hu K, Wu C, Mars WM, Liu Y. Tissue-type plasminogen activator promotes murine myofibroblast activation through LDL receptor-related protein 1\u2013mediated integrin signaling. J Clin Invest, 2007, 117:","journal-title":"J Clin Invest"},{"key":"CITATION42","doi-asserted-by":"publisher","first-page":"22887","DOI":"10.3390\/ijms151222887","volume":"15","author":"Lin L","year":"2014","unstructured":"Lin L, Hu K. LRP-1: functions, signaling and implications in kidney  and other diseases. Int J Mol Sci, 2014, 15: 22887-22901.","journal-title":"Int J Mol Sci"},{"key":"CITATION43","doi-asserted-by":"publisher","first-page":"111758","DOI":"10.1016\/j.biopha.2021.111758","volume":"140","author":"Mahboobnia K","year":"2021","unstructured":"Mahboobnia K, Pirro M, Marini E, Grignani F, Bezsonov EE, Jamialahmadi T, Sahebkar A. PCSK9 and cancer: rethinking the link. Biomed Pharmacother, 2021, 140:","journal-title":"Biomed Pharmacother"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.sciengine.com\/doi\/pdf\/EB4596FB68324C44AF6971B5FFCA4C51","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2025034","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/pdf\/EB4596FB68324C44AF6971B5FFCA4C51","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:46:34Z","timestamp":1761882394000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2025034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,13]]},"references-count":43,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,6,13]]},"published-print":{"date-parts":[[2025,10,1]]}},"URL":"https:\/\/doi.org\/10.3724\/abbs.2025034","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.01.06.631433","asserted-by":"object"}]},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,13]]}}}